Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Erasca, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- +14 vs. Q3 2023
- Shares held
- 69.2M
- +323.3K (+0.5%) vs. Q3 2023
- Total value
- $147.5M
- +$11.8M (+8.7%) vs. Q3 2023
- New holders
- 28
- 41 more added
- Sold out
- 14
- 35 more reduced
4 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 256 | $5.13B |
| Q1 2026 | 225 | $4.39B |
| Q4 2025 | 154 | $815.7M |
| Q3 2025 | 141 | $468.5M |
| Q2 2025 | 142 | $277.1M |
| Q1 2025 | 154 | $307.3M |
| Q4 2024 | 146 | $579.5M |
| Q3 2024 | 132 | $633.4M |
| Q2 2024 | 126 | $480.6M |
| Q1 2024 | 108 | $149.7M |
| Q4 2023 | 119 | $147.5M |
| Q3 2023 | 109 | $140.4M |
| Q2 2023 | 112 | $205.2M |
| Q1 2023 | 118 | $234.9M |
| Q4 2022 | 107 | $343.9M |
| Q3 2022 | 88 | $627.9M |
| Q2 2022 | 89 | $428.3M |
| Q1 2022 | 82 | $626.6M |
| Q4 2021 | 63 | $988.0M |
| Q3 2021 | 55 | $919.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Erasca, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 726,751 | $1.55M | 0.00% | +186,435+34.5% | Added |
| EDBI Pte Ltd | 888,888 | $1.89M | 1.87% | 00.0% | Unchanged |
| Woodline Partners LP | 919,119 | $1.96M | 0.02% | +795,546+643.8% | Added |
| Two Sigma Investments, LP | 997,419 | $2.12M | 0.01% | +563,282+129.7% | Added |
| Nuveen Asset Management, LLC | 1,199,952 | $2.56M | 0.00% | +2,012+0.2% | Added |
| Goldman Sachs Group Inc | 1,297,042 | $2.76M | 0.00% | +633,192+95.4% | Added |
| Millennium Management LLC | 1,484,608 | $3.16M | 0.00% | +1,068,501+256.8% | Added |
| State Street Corp | 1,665,304 | $3.55M | 0.00% | +170,239+11.4% | Added |
| Geode Capital Management, LLC | 1,811,911 | $3.86M | 0.00% | +96,518+5.6% | Added |
| Schroder Investment Management Group | 1,926,000 | $4.10M | 0.01% | +1,926,000 | New |
| Renaissance Technologies LLC | 2,008,500 | $4.28M | 0.01% | +1,266,400+170.7% | Added |
| Citadel Advisors LLC | 2,147,594 | $4.57M | 0.00% | +384,949+21.8% | Added |
| PFM Health Sciences, LP | 2,575,511 | $5.49M | 0.33% | −1,355,122−34.5% | Reduced |
| AH Capital Management, L.L.C. | 2,862,500 | $6.10M | 0.38% | +2,862,500 | New |
| Vanguard Group Inc | 3,792,343 | $8.08M | 0.00% | −1,322,769−25.9% | Reduced |
| Artal Group S.A. | 4,721,194 | $10.1M | 0.34% | 00.0% | Unchanged |
| BlackRock Inc. | 7,310,321 | $15.6M | 0.00% | +283,078+4.0% | Added |
| Armistice Capital, LLC | 8,096,000 | $17.2M | 0.46% | −260,000−3.1% | Reduced |
| ARCH Venture Management, LLC | 11,055,554 | $23.5M | 14.40% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −10,813,246−100.0% | Sold out |
| ArrowMark Colorado Holdings LLC | 0 | $0 | 0.00% | −233,400−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −120,892−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −42,651−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −36,494−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −15,319−100.0% | Sold out |
| Private Capital Advisors, Inc. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −13,058−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −12,324−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −11,609−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −9,798−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −5,568−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −922−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| AH Equity Partners LSV II, L.L.C. | – | – | – | – | Not filed |
| Innovis Asset Management LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |